Browse studies

Find your next paid study

101 recruiting studies matching your filters

Genome Transplant Dynamics

Study Description: Heart and lung transplants can save lives, but long-term success is often limited by organ rejection that is hard to detect early. This stu…

Thoracic Organ Transplantation

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT02423070

Phase 1

Phase I Trial of [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Background: Some cancers have high levels of proteins called somatostatin receptors (SSTRs) on the surface of the tumors. These tumors can be in the lung, hea…

Sinonasal Neuroendocrine CarcinomaNasopharyngeal CarcinomaEsthesioneuroblastoma+7 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06479811

Phase 3

A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, …

Ganglioneuroblastoma, NodularNeuroblastoma

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06172296

Phase 4

Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pain Management

The goal of this clinical trial is to determine whether suzetrigine, when added to standardized multimodal postoperative analgesia improves pain control and re…

Pelvic Organ Prolapse (POP)Postoperative PainUrogynecology

Estimated

~$10 – $7,500

Aditi TalkadNCT07856654

Phase 3

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiat…

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05675410

Phase 2

A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).

Advanced Pheochromocytoma and ParagangliomaPCPG

Estimated

~$10 – $8,750

Jazz PharmaceuticalsNCT07282587

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)

In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). IgAN is a kidney disease caus…

Immunoglobulin A Nephropathy (IgAN)

Estimated

~$10 – $7,500

BiogenNCT06935357

Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Background: People with sickle cell disease (SCD) have problems with their heart, brain, kidneys, liver, and lungs as they age. These problems may improve aft…

Mortality in Sickle CellSickle Cell Cardiopulmonary ComplicationsSickle Cell Organ Damage+2 more

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT05213572

Observational

Feeding the Flame, One Day at a Time: Design and Acceptability of a Serious Game to Support Medication Adherence and Education for Pediatric Solid Organ Transplant Patients

Children and teenagers who receive a solid organ transplant (such as a kidney, liver, or heart) must take medications every day to keep their new organ healthy…

Solid Organ Transplant

Estimated

~$10 – $6,250

Stanford UniversityNCT07609303

The Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Background: People s bodies need to break down food into the chemicals. These chemicals are used for energy and growth. Some people cannot process all chemica…

Metabolic DiseasePropionic AcidemiaOrganic Acidemia

Estimated

~$10 – $675

National Human Genome Research Institute (NHGRI)NCT02890342

Phase 2

A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations

This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic n…

Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT04924075

Phase 3

18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in lat…

Niemann-Pick Type C DiseaseGM1 GangliosidosisGM2 Gangliosidosis

Estimated

~$10 – $7,500

Azafaros B.V.NCT07054515